OpenURL Connection Search

Select item for more details and to access through your institution.

Advancements in glucagon-like peptide-1 receptor agonist therapy for type 2 diabetes.
Published in:
Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 8, p. 667, doi. 10.5246/jcps.2024.08.050
By:
- Yaping Peng;
- Ying Fu
Publication type:
Article
Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus.
Published in:
Sultan Qaboos University Medical Journal, 2024, v. 24, n. 3, p. 418, doi. 10.18295/SQUMJ.8.2024.050
By:
- Raza, Hunain;
- Bhutta, Muhammad E.;
- Siddique, Muhammad H.
Publication type:
Article
Lifelong impact of adiposity on cardiac structure and function: an alarming signal.
Published in:
European Heart Journal, 2024, v. 45, n. 33, p. 3069, doi. 10.1093/eurheartj/ehae443
By:
- Roever, Leonardo;
- Tse, Gary;
- Biondi-Zoccai, Giuseppe
Publication type:
Article
The effectiveness of 0.5 mg and 1mg of semaglutide in patients with type two diabetes and predictors of response: a retrospective cohort study.
Published in:
Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2024.1395651
By:
- Alenzi, Sara;
- Alzahrani, Abdullah;
- Aljaloud, Afnan;
- Alanazi, Kamayel;
- Alarfaj, Sumaiah J.
Publication type:
Article
Comparative effects of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors on heart failure with preserved ejection fraction in diabetic patients: a meta-analysis.
Published in:
Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02415-8
By:
- Albulushi, Arif;
- Tanoh, Desmond Boakye;
- Almustafa, Ahmed;
- Al Matrooshi, Nadya;
- Zolty, Ronald;
- Lowes, Brian
Publication type:
Article
Beyond Glycemic Control: GLP-1 Receptor Agonists and Their Impact on Calcium Homeostasis in Real-World Patients.
Published in:
Journal of Clinical Medicine, 2024, v. 13, n. 16, p. 4896, doi. 10.3390/jcm13164896
By:
- Alenezi, Bandar T.;
- Elfezzani, Nadra;
- Uddin, Rukhsana;
- Patel, Hinali;
- Chester, Sydney;
- Abdelmaksoud, Ahmed;
- Hussein, Mohammad H.;
- Zaitone, Sawsan A.;
- Fawzy, Manal S.;
- Aiash, Hani;
- Toraih, Eman A.
Publication type:
Article
Oral Semaglutide in Type 2 Diabetes: Clinical–Metabolic Outcomes and Quality of Life in Real-World Practice.
Published in:
Journal of Clinical Medicine, 2024, v. 13, n. 16, p. 4752, doi. 10.3390/jcm13164752
By:
- Pantanetti, Paola;
- Ronconi, Vanessa;
- Sguanci, Marco;
- Palomares, Sara Morales;
- Mancin, Stefano;
- Tartaglia, Francesco Carlo;
- Cangelosi, Giovanni;
- Petrelli, Fabio
Publication type:
Article
Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs.
Published in:
Journal of Clinical Medicine, 2024, v. 13, n. 16, p. 4674, doi. 10.3390/jcm13164674
By:
- Le, Richard;
- Nguyen, Mau T.;
- Allahwala, Momina A.;
- Psaltis, James P.;
- Marathe, Chinmay S.;
- Marathe, Jessica A.;
- Psaltis, Peter J.
Publication type:
Article
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis.
Published in:
Diabetology & Metabolic Syndrome, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13098-024-01448-z
By:
- Mao, Tianshi;
- Chen, Jie;
- Su, Tong;
- Xie, Long;
- Qu, Xinyan;
- Feng, Ruli;
- Pan, Yi;
- Wan, Jie;
- Cui, Xiaoyun;
- Jia, Wenhao;
- Gao, Qun;
- Lin, Qian
Publication type:
Article
Rational Design of a Humanized Glucagon-Like Peptide-1 Receptor Agonist Antibody.
Published in:
Angewandte Chemie, 2015, v. 127, n. 7, p. 2154, doi. 10.1002/ange.201410049
By:
- Zhang, Yong;
- Zou, Huafei;
- Wang, Ying;
- Caballero, Dawna;
- Gonzalez, Jose;
- Chao, Elizabeth;
- Welzel, Gus;
- Shen, Weijun;
- Wang, Danling;
- Schultz, Peter G.;
- Wang, Feng
Publication type:
Article
Glucagon-like Peptide-1 Receptor Agonists and Diabetic Osteopathy: Another Positive Effect of Incretines? A 12 Months Longitudinal Study.
Published in:
Calcified Tissue International, 2024, v. 115, n. 2, p. 160, doi. 10.1007/s00223-024-01240-1
By:
- Al Refaie, Antonella;
- Baldassini, Leonardo;
- Mondillo, Caterina;
- Ceccarelli, Elena;
- Tarquini, Roberto;
- Gennari, Luigi;
- Gonnelli, Stefano;
- Caffarelli, Carla
Publication type:
Article
Narrative Review of Effects of Glucagon-Like Peptide-1 Receptor Agonists on Bone Health in People Living with Obesity.
Published in:
Calcified Tissue International, 2024, v. 114, n. 2, p. 86, doi. 10.1007/s00223-023-01150-8
By:
- Herrou, Julia;
- Mabilleau, Guillaume;
- Lecerf, Jean-Michel;
- Thomas, Thierry;
- Biver, Emmanuel;
- Paccou, Julien
Publication type:
Article
GLP-1RAs inhibit the activation of the NLRP3 inflammasome signaling pathway to regulate mouse renal podocyte pyroptosis.
Published in:
Acta Diabetologica, 2024, v. 61, n. 2, p. 225, doi. 10.1007/s00592-023-02184-y
By:
- Li, Xiang;
- Jiang, Xiao;
- Jiang, Mei;
- Wang, Zhi-feng;
- Zhao, Tao;
- Cao, Si-ming;
- Li, Qiu-Mei
Publication type:
Article
The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy.
Published in:
Acta Diabetologica, 2023, v. 60, n. 11, p. 1551, doi. 10.1007/s00592-023-02135-7
By:
- Oezer, Kuebra;
- Kolibabka, Matthias;
- Gassenhuber, Johann;
- Dietrich, Nadine;
- Fleming, Thomas;
- Schlotterer, Andrea;
- Morcos, Michael;
- Wohlfart, Paulus;
- Hammes, Hans-Peter
Publication type:
Article
De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes.
Published in:
Acta Diabetologica, 2023, v. 60, n. 1, p. 53, doi. 10.1007/s00592-022-01974-0
By:
- Falcetta, Pierpaolo;
- Nicolì, Francesca;
- Citro, Fabrizia;
- Ciccarone, Annamaria;
- Garofolo, Monia;
- Del Prato, Stefano;
- Bianchi, Cristina
Publication type:
Article
γ-aminobutyric acid modulates α-cell hyperplasia but not β-cell regeneration induced by glucagon receptor antagonism in type 1 diabetic mice.
Published in:
Acta Diabetologica, 2023, v. 60, n. 1, p. 19, doi. 10.1007/s00592-022-01970-4
By:
- Gu, Liangbiao;
- Cui, Xiaona;
- Lin, Xiafang;
- Yang, Jin;
- Wei, Rui;
- Hong, Tianpei;
- Yang, Kun
Publication type:
Article
Usefulness of circulating EPAC1 as biomarkers of therapeutic response to GLP-1 receptor agonists.
Published in:
Acta Diabetologica, 2022, v. 59, n. 11, p. 1437, doi. 10.1007/s00592-022-01928-6
By:
- Hernández, Cristina;
- Gómez-Peralta, Fernando;
- Simó-Servat, Olga;
- García-Ramírez, Marta;
- Abreu, Cristina;
- Gómez-Rodríguez, Sara;
- Simó, Rafael
Publication type:
Article
Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis.
Published in:
Acta Diabetologica, 2022, v. 59, n. 4, p. 519, doi. 10.1007/s00592-021-01830-7
By:
- Ding, Chen;
- Tang, Yaxin;
- Zhu, Wenqiang;
- Huang, Piaopiao;
- Lian, Pingan;
- Ran, Juanli;
- Huang, Xiansheng
Publication type:
Article
Glucagon-like peptide-1 receptor agonists (GLP1-RA) in the treatment of mitochondrial diabetes.
Published in:
Acta Diabetologica, 2021, v. 58, n. 9, p. 1281, doi. 10.1007/s00592-021-01729-3
By:
- Lebbar, Maha;
- Timsit, José;
- Luyton, Cédric;
- Marchand, Lucien
Publication type:
Article
High baseline FGF21 levels are associated with poor glucose-lowering efficacy of exenatide in patients with type 2 diabetes.
Published in:
Acta Diabetologica, 2021, v. 58, n. 5, p. 595, doi. 10.1007/s00592-020-01660-z
By:
- Yang, Kun;
- Wang, Haining;
- Wei, Rui;
- Xiao, Wenhua;
- Tian, Qing;
- Wang, Chen;
- Yang, Jin;
- Hong, Tianpei
Publication type:
Article
Incretin mimetics and sodium-glucose co-transporter 2 inhibitors as monotherapy or add-on to metformin for treatment of type 2 diabetes: a systematic review and network meta-analysis.
Published in:
Acta Diabetologica, 2021, v. 58, n. 1, p. 5, doi. 10.1007/s00592-020-01542-4
By:
- Jia, Shubing;
- Wang, Zhiying;
- Han, Ruobing;
- Zhang, Zinv;
- Li, Yuping;
- Qin, Xiaotong;
- Zhao, Mingyi;
- Xiang, Rongwu;
- Yang, Jingyu
Publication type:
Article
Alternative methods for assessing glycemia might prove useful in cases of discordance between glycated hemoglobin and self-monitoring of blood glucose.
Published in:
2020
By:
- Koufakis, Theocharis;
- Kotsa, Kalliopi
Publication type:
Letter
The effects of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 receptor agonists on cognitive functions in adults with type 2 diabetes mellitus: a systematic review and meta-analysis.
Published in:
Acta Diabetologica, 2020, v. 57, n. 10, p. 1129, doi. 10.1007/s00592-020-01529-1
By:
- Jin, Yuxin;
- Zhao, Hang;
- Hou, Yilin;
- Song, Guangyao
Publication type:
Article
Species differences in pancreatic binding of DO3A-VS-Cys-Exendin4.
Published in:
Acta Diabetologica, 2017, v. 54, n. 11, p. 1039, doi. 10.1007/s00592-017-1046-2
By:
- Eriksson, Olof;
- Rosenström, Ulrika;
- Selvaraju, Ram;
- Eriksson, Barbro;
- Velikyan, Irina
Publication type:
Article
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials.
Published in:
Acta Diabetologica, 2017, v. 54, n. 10, p. 933, doi. 10.1007/s00592-017-1031-9
By:
- Dicembrini, Ilaria;
- Nreu, Besmir;
- Scatena, Alessia;
- Andreozzi, Francesco;
- Sesti, Giorgio;
- Mannucci, Edoardo;
- Monami, Matteo
Publication type:
Article
Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide.
Published in:
2014
By:
- Faurschou, A.;
- Knop, F.;
- Thyssen, J.;
- Zachariae, C.;
- Skov, L.;
- Vilsbøll, T.
Publication type:
Report
Achieving glycemic control in patients with type 2 diabetes and renal impairment.
Published in:
Acta Diabetologica, 2013, v. 50, n. 3, p. 283, doi. 10.1007/s00592-012-0442-x
By:
- Avogaro, Angelo;
- Schernthaner, Guntram
Publication type:
Article
The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective.
Published in:
2019
By:
- Jensterle, Mojca;
- Janez, Andrej;
- Fliers, Eric;
- DeVries, J Hans;
- Vrtacnik-Bokal, Eda;
- Siegelaar, Sarah E
Publication type:
journal article
Glucagon-like peptide-1 receptor agonist (GLP1-RA) therapy in type 2 diabetes.
Published in:
Australian Journal of General Practice, 2022, v. 51, n. 7, p. 513, doi. 10.31128/ajgp-07-21-6057
By:
- Ng, Elisabeth;
- Shaw, Jonathan E.;
- Wood, Anna;
- Maple-Brown, Louise J.;
- Hare, Matthew J. L.
Publication type:
Article
Exendin-4高活性短肽模拟物的筛选及生物活性.
Published in:
Journal of Jilin University (Science Edition) / Jilin Daxue Xuebao (Lixue Ban), 2019, v. 57, n. 3, p. 696, doi. 10.13413/j.cnki.jdxblxb.2018207
By:
- 宋相伟;
- 王雪丽;
- 王璐璐;
- 楼婉琳;
- 王丽萍;
- 熊新辉;
- 牛建丽;
- 李惟
Publication type:
Article
Glucagon-Like Peptide-1 Receptor Agonists for Chronic Weight Management.
Published in:
Advances in Medicine, 2023, p. 1, doi. 10.1155/2023/9946924
By:
- Wojtara, Magda;
- Mazumder, Ashmita;
- Syeda, Yusra;
- Mozgała, Nikodem
Publication type:
Article
Risk of Severe Hypoglycemia With Newer Second-line Glucose-lowering Medications in Older Adults With Type 2 Diabetes Stratified by Known Indicators of Hypoglycemia Risk.
Published in:
Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2023, v. 78, n. 12, p. 2426, doi. 10.1093/gerona/glad075
By:
- Htoo, Phyo T;
- Paik, Julie M;
- Alt, Ethan;
- Kim, Dae Hyun;
- Wexler, Deborah J;
- Kim, Seoyoung C;
- Patorno, Elisabetta
Publication type:
Article
GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes.
Published in:
Cells (2073-4409), 2024, v. 13, n. 1, p. 65, doi. 10.3390/cells13010065
By:
- Wilbon, Sydney S.;
- Kolonin, Mikhail G.
Publication type:
Article
Slowing the Progression of Diabetic Kidney Disease.
Published in:
Cells (2073-4409), 2023, v. 12, n. 15, p. 1975, doi. 10.3390/cells12151975
By:
- Blazek, Olivia;
- Bakris, George L.
Publication type:
Article
Glucagon Promotes Gluconeogenesis through the GCGR/PKA/CREB/PGC-1α Pathway in Hepatocytes of the Japanese Flounder Paralichthys olivaceus.
Published in:
Cells (2073-4409), 2023, v. 12, n. 7, p. 1098, doi. 10.3390/cells12071098
By:
- Yang, Mengxi;
- Pan, Mingzhu;
- Huang, Dong;
- Liu, Jiahuan;
- Guo, Yanlin;
- Liu, Yue;
- Zhang, Wenbing
Publication type:
Article
Induced Human Regulatory T Cells Express the Glucagon-like Peptide-1 Receptor.
Published in:
Cells (2073-4409), 2022, v. 11, n. 16, p. 2587, doi. 10.3390/cells11162587
By:
- Rode, Anna K. O.;
- Buus, Terkild Brink;
- Mraz, Veronika;
- Al-Jaberi, Fatima Abdul Hassan;
- Lopez, Daniel Villalba;
- Ford, Shayne L.;
- Hennen, Stephanie;
- Eliasen, Ina Primon;
- Klewe, Ib Vestergaard;
- Gharehdaghi, Leila;
- Dragan, Adrian;
- Rosenkilde, Mette M.;
- Woetmann, Anders;
- Skov, Lone;
- Ødum, Niels;
- Bonefeld, Charlotte M.;
- Kongsbak-Wismann, Martin;
- Geisler, Carsten
Publication type:
Article
Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype.
Published in:
Cells (2073-4409), 2021, v. 10, n. 11, p. 3193, doi. 10.3390/cells10113193
By:
- Jagomäe, Toomas;
- Seppa, Kadri;
- Reimets, Riin;
- Pastak, Marko;
- Plaas, Mihkel;
- Hickey, Miriam A.;
- Kukker, Kaia Grete;
- Moons, Lieve;
- De Groef, Lies;
- Vasar, Eero;
- Kaasik, Allen;
- Terasmaa, Anton;
- Plaas, Mario
Publication type:
Article
Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose.
Published in:
Cells (2073-4409), 2021, v. 10, n. 9, p. 2495, doi. 10.3390/cells10092495
By:
- Zhang, Yulin;
- Han, Chengsheng;
- Zhu, Wenzhen;
- Yang, Guoyi;
- Peng, Xiaohong;
- Mehta, Sohum;
- Zhang, Jin;
- Chen, Liangyi;
- Liu, Yanmei
Publication type:
Article
Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach.
Published in:
Brain Sciences (2076-3425), 2024, v. 14, n. 6, p. 617, doi. 10.3390/brainsci14060617
By:
- Arillotta, Davide;
- Floresta, Giuseppe;
- Papanti Pelletier, G. Duccio;
- Guirguis, Amira;
- Corkery, John Martin;
- Martinotti, Giovanni;
- Schifano, Fabrizio
Publication type:
Article
GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach.
Published in:
Brain Sciences (2076-3425), 2023, v. 13, n. 11, p. 1503, doi. 10.3390/brainsci13111503
By:
- Arillotta, Davide;
- Floresta, Giuseppe;
- Guirguis, Amira;
- Corkery, John Martin;
- Catalani, Valeria;
- Martinotti, Giovanni;
- Sensi, Stefano L.;
- Schifano, Fabrizio
Publication type:
Article
Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events.
Published in:
Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1416985
By:
- Long He;
- Qiuyu Li;
- Yongfeng Yang;
- Jiahao Li;
- Wei Luo;
- Yilan Huang;
- Xiaoyan Zhong
Publication type:
Article
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects.
Published in:
Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1422740
By:
- Riemma, Maria Antonietta;
- Mele, Elena;
- Donniacuo, Maria;
- Telesca, Marialucia;
- Bellocchio, Gabriella;
- Castaldo, Giuseppe;
- Rossi, Francesco;
- De Angelis, Antonella;
- Cappetta, Donato;
- Urbanek, Konrad;
- Berrino, Liberato
Publication type:
Article
A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database.
Published in:
Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1397029
By:
- Liyuan Liu
Publication type:
Article
Adverse events in different administration routes of semaglutide: a pharmacovigilance study based on the FDA adverse event reporting system.
Published in:
Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1414268
By:
- Kaibin Niu;
- Maoxia Fan;
- Wulin Gao;
- Chen Chen;
- Guohua Dai
Publication type:
Article
Improving glycemic control: transitioning from dulaglutide to tirzepatide in patients with type 2 diabetes undergoing hemodialysis.
Published in:
Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1362242
By:
- Emiko Otsuka;
- Mineaki Kitamura;
- Satoshi Funakoshi;
- Hiroshi Mukae;
- Tomoya Nishino
Publication type:
Article
Pancreatitis with use of new diabetic medications: a real-world data study using the post-marketing FDA adverse event reporting system (FAERS) database.
Published in:
Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1364110
By:
- Alenzi, Khalidah A.;
- Alsuhaibani, Deemah;
- Batarfi, Bader;
- Alshammari, Thamir M.
Publication type:
Article
Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease.
Published in:
Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1396656
By:
- Tianyu Wang;
- Juncan Ding;
- Xinyi Cheng;
- Qiang Yang;
- Pengfei Hu
Publication type:
Article
Real-world effectiveness of GLP-1 receptor agonist-based treatment strategies on “time in range” in patients with type 2 diabetes.
Published in:
Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1370594
By:
- Yongru Chen;
- Jingxian Chen;
- Shuo Zhang;
- Dan Zhu;
- Feiying Deng;
- Rui Zuo;
- Yufei Hu;
- Yue Zhao;
- Yale Duan;
- Benwei Lin;
- Fengwu Chen;
- Yun Liang;
- Jiaxiong Zheng;
- Khan, Barkat Ali;
- Kaijian Hou
Publication type:
Article
Evolving role of semaglutide in NAFLD: in combination, weekly and oral administration.
Published in:
Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1343587
By:
- Koureta, Evgenia;
- Cholongitas, Evangelos
Publication type:
Article
Comparative effects of incretin-based therapy on doxorubicin-induced nephrotoxicity in rats: the role of SIRT1/Nrf2/NF-κB/TNF-α signaling pathways.
Published in:
Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1353029
By:
- Botros, Sandy R.;
- Matouk, Asmaa I.;
- Amin, Amr;
- Heeba, Gehan H.
Publication type:
Article

Found: 1662